Home
What We Do
Playlists
Content Library
HER2+
HR+
HER2-Low / Ultra-Low
Triple Negative
High Risk
Podcasts
Breast Friends
Apple Podcasts
Spotify
Amazon Music
iHeartRadio
Castbox
Goodpods
Pocket Casts
Contact Us
···
Youtube
Facebook
LinkedIn
Instagram
Home
What We Do
Playlists
Content Library
HER2+
HR+
HER2-Low / Ultra-Low
Triple Negative
High Risk
Podcasts
Breast Friends
Apple Podcasts
Spotify
Amazon Music
iHeartRadio
Castbox
Goodpods
Pocket Casts
Contact Us
···
Youtube
Facebook
LinkedIn
Instagram
Home
What We Do
Playlists
Content Library
HER2+
HR+
HER2-Low / Ultra-Low
Triple Negative
High Risk
Podcasts
Breast Friends
Apple Podcasts
Spotify
Amazon Music
iHeartRadio
Castbox
Goodpods
Pocket Casts
Contact Us
DESTINY-Breast09 & the Future of Care – Dr. Irene Kang & Dr. Aditya Bardia
Playlist - Dr. Irene Kang & Dr. Aditya Bardia
Video
Why First-Line Therapy Matters in HER2+ Metastatic Breast Cancer
1 min read
Video
DESTINY-Breast09: Nearly 4 Years of PFS with T-DXd
1 min read
Video
Who Should Receive T-DXd First Line?
1 min read
Video
Managing Risk vs Benefit with T-DXd
1 min read
Video
Dose Optimization: The Secret to Long-Term T-DXd Success
1 min read
Video
Monitoring ILD with T-DXd: What Clinicians Need to Know
1 min read
Video
What Comes After DESTINY-Breast09?
1 min read
Video
Induction to Maintenance: Is This the Future of ADCs in 1st line HER2+ mBC?
1 min read
